Century and Bristol Myers Squibb collaborate to develop iPSC-derived allogeneic cell therapies Jan. 11, 2022
EsoCap and Upadia sign licensing agreement to develop therapeutics to treat Barrett's esophagus Jan. 10, 2022
Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems Jan. 10, 2022
NHMRC grant supports exploration of Pharmaxis serine protease inhibitor for tissue repair Jan. 10, 2022
Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206 Jan. 7, 2022
RSS